Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Pharmaceuticals division also comprises the radiology business. The Consumer Health segment is engaged in the development, production and marketing of mainly nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products. The Covestro segment is engaged in the development, production and marketing of raw materials for polyurethanes, polycarbonate granules and sheets and raw materials for coatings, adhesives.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Symbol: OTC:BAYRY
- CUSIP: N/A
- Web: www.bayer.com
- Market Cap: $113.78 billion
- Outstanding Shares: 871,387,000
- 52 Week Range: $91.53 - $139.04
Sales & Book Value:
- Trailing P/E Ratio:
- Foreward P/E Ratio: 13.39
- P/E Growth:
- Annual Revenue: $55.26 billion
- Price / Sales: 2.06
- Book Value: $44.27 per share
- Price / Book: 2.95
- Annual Dividend: $2.16
- Dividend Yield: 2.3%
- EBIDTA: $13.18 billion
- Net Margins: 10.56%
- Return on Equity: 21.88%
- Return on Assets: 7.43%
- Debt-to-Equity Ratio: 0.69%
- Current Ratio: 1.53%
- Quick Ratio: 1.05%
Frequently Asked Questions for Bayer AG (OTC:BAYRY)
What is Bayer AG's stock symbol?
Bayer AG trades on the OTC under the ticker symbol "BAYRY."
Who are some of Bayer AG's key competitors?
Some companies that are related to Bayer AG include Roche Holding (RHHBY), Novartis AG (NVS), Pfizer (PFE), UnitedHealth Group Incorporated (UNH), Merck & Company (MRK), Amgen (AMGN), Sanofi (SNY), Medtronic PLC (MDT), AbbVie (ABBV), Celgene Corporation (CELG), Novo Nordisk A/S (NVO), GlaxoSmithKline PLC (GSK), Gilead Sciences (GILD), Bristol-Myers Squibb Company (BMY), Abbott Laboratories (ABT), Eli Lilly and Company (LLY), Allergan plc (AGN) and Astrazeneca PLC (AZN).
Who are Bayer AG's key executives?
Bayer AG's management team includes the folowing people:
- Werner Wenning, Chairman of the Supervisory Board
- Werner Baumann, Chairman of the Management Board, Chief Executive Officer
- Oliver Zuehlke, Vice Chairman of the Supervisory Board, Employee Representative
- Johannes M. Dietsch, Chief Financial Officer, Member of the Management Board
- Hartmut Klusik, Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director
- Liam Condon, Member of the Management Board, Head of the Crop Science Division, Animal Health Business Unit
- Kemal Malik, Member of the Management Board, Innovation and the Latin America Region
- Erica Mann, Member of the Management Board, Head of the Consumer Health Division
- Dieter Weinand, Member of the Management Board, Head of the Pharmaceuticals Division
- Paul Achleitner, Member of the Supervisory Board
How do I buy Bayer AG stock?
Shares of Bayer AG can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Bayer AG's stock price today?
MarketBeat Community Rating for Bayer AG (OTC BAYRY)MarketBeat's community ratings are surveys of what our community members think about Bayer AG and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Bayer AG stock can currently be purchased for approximately $130.57.
Consensus Ratings for Bayer AG (OTC:BAYRY) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Hold Rating|
|Consensus Rating:||Hold (Score: 2.00)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Bayer AG (OTC:BAYRY)
(Data available from 7/26/2015 forward)
|7/3/2017||Berenberg Bank||Downgrade||Buy -> Hold|
Earnings History for Bayer AG (OTC:BAYRY)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Bayer AG (OTC:BAYRY)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Bayer AG (OTC:BAYRY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Bayer AG (OTC:BAYRY)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Bayer AG (OTC:BAYRY)
Latest Headlines for Bayer AG (OTC:BAYRY)